|
|
Article: Lactobacillus GG for prevention of childhood eczema. (Literature Review & Commentary).(Brief Article)
- Article from:
- Townsend Letter for Doctors and Patients
- Article date:
- May 1, 2003
- Author:
CopyrightCOPYRIGHT 2003 The Townsend Letter Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
One hundred fifty-nine pregnant women who had at least one first-degree relative (or partner) with atopic eczema, allergic rhinitis, or asthma were randomly assigned to receive, in double-blind fashion, Lactobacillus GG ([10.sup.10] colony-forming units per day) or placebo for 2-4 weeks before expected delivery. After delivery, breastfeeding mothers continued their respective treatment, whereas non-breastfeeding infants were given the active treatment or placebo orally for 6 months. At 2 years of age, the prevalence of atopic eczema in the Lactobacillus GG group was 23.5%, compared with 45.6% in the placebo group (48.4% reduction; p = 0.008).
...